CD8A and neoplasm: These data showed that Y111 prompted the lysis of H358 cells mediated by the fresh CD8+ T cells but spared this effect on the fresh Vδ2 T cells enriched from the same donors, which suggested that Y111 could bypass the anti-tumor capacity of the fresh Vγ2Vδ2 T cells.